Figure 7. Resveratrol alleviates NTHi-induced inflammation by counteracting ERK-dependent down-regulation of MyD88s via a cAMP-PKA-MKP-1 pathway.
The anti-inflammatory effects of resveratrol are mediated by a cAMP-PKA-MKP-1 pathway that suppresses of ERK-dependent down-regulation of NTHi-induced MyD88s in airway epithelial cells.